Krusat T, Streckert H J
Department of Medical Microbiology and Virology, Ruhr-University, Bochum, Germany.
Arch Virol. 1997;142(6):1247-54. doi: 10.1007/s007050050156.
In this study we could demonstrate that heparin (ED50 = 0.32 +/- 0.12 microgram/ml), but not heparan sulphate or chondroitin sulphate C is able to inhibit in vitro infection of cells by respiratory syncytial virus (RSV). In addition, this protective effect of heparin could only be observed, when heparin was present at the time of inoculation. Enzymatic digestion of cell surface glycosaminoglycans with heparinase and heparitinase, but not chondroitin sulphate ABC lyase reduced the effectiveness of RSV-infection. Affinity chromatography experiments, using immobilised heparin further demonstrated that RSV attachment protein G was able to bind specifically to heparin. Therefore heparin-like proteoglycans showed properties required for attachment of RSV to host cells.
在本研究中,我们能够证明肝素(半数有效剂量=0.32±0.12微克/毫升),而非硫酸乙酰肝素或硫酸软骨素C能够在体外抑制呼吸道合胞病毒(RSV)对细胞的感染。此外,只有在接种时存在肝素,才能观察到这种肝素的保护作用。用肝素酶和乙酰肝素酶对细胞表面糖胺聚糖进行酶消化,但不用硫酸软骨素ABC裂解酶,会降低RSV感染的有效性。使用固定化肝素的亲和层析实验进一步证明,RSV附着蛋白G能够特异性结合肝素。因此,类肝素蛋白聚糖表现出RSV附着于宿主细胞所需的特性。